Therapeutic Asset Ratings
6,308 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Cytokine-Treated Veto Cells
Plasma Cell Myeloma
M.D. Anderson Cancer Center
P1/2
CCC
(48)
d2c7-it
Glioblastoma
Darell Bigner
P1/2
CCC
(48)
d3s-002
Cancer
D3 Bio (Wuxi) Co., Ltd
P1/2
CCC
(48)
Daraxonrasib
Colorectal Cancer
Revolution Medicines, Inc.
P1/2
CCC
(48)
Darolutamide
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1/2
CCC
(48)
Darolutamide
Male Reproductive System Disorder
Celcuity Inc
P1/2
CCC
(48)
Darolutamide
Prostate Disorder
Celcuity Inc
P1/2
CCC
(48)
Dasatinib
Metabolic Dysfunction-Associated Steatotic Liver Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
P1/2
CCC
(48)
Datopotamab Deruxtecan
Small Cell Lung Carcinoma
AstraZeneca
P1/2
CCC
(48)
db107-fc
Glioblastoma
University of California, San Francisco
P1/2
CCC
(48)
db107-rrv
Glioblastoma
University of California, San Francisco
P1/2
CCC
(48)
Decitabine
Synovial Sarcoma
Roswell Park Cancer Institute
P1/2
CCC
(48)
Decitabine
Castration-Resistant Prostate Carcinoma
Roswell Park Cancer Institute
P1/2
CCC
(48)
Decitabine
Non-Hodgkin Lymphoma
Chinese PLA General Hospital
P1/2
CCC
(48)
Decoy20
Urothelial Carcinoma
Indaptus Therapeutics, Inc
P1/2
CCC
(48)
Deoxycholic Acid
Ovarian Serous Adenocarcinoma
THERAPIM PTY LTD
P1/2
CCC
(48)
Dermaprazole 2%
Radiodermatitis
Baylor College of Medicine
P1/2
CCC
(48)
DESFERRIOXAMINE B
Brain Aneurysm
Radboud University Medical Center
P1/2
CCC
(48)
DESFERRIOXAMINE B
Subarachnoid Hemorrhage
Radboud University Medical Center
P1/2
CCC
(48)
Deucrictibant
Angioedema
Institute for Asthma and Allergy
P1/2
CCC
(48)
DEVAFIDUGENE CIVAPARVOVEC
Mucopolysaccharidosis Type 1
Sangamo Therapeutics
P1/2
CCC
(48)
DEXAMETHASONE
Large Intestine Disorder
University of Saskatchewan
P1/2
CCC
(48)
DEXAMETHASONE
Local Anesthetic Poisoning
University of Saskatchewan
P1/2
CCC
(48)
DEXAMETHASONE
Oropharyngeal Carcinoma
National Cancer Institute (NCI)
P1/2
CCC
(48)
DEXAMETHASONE
Head And Neck Squamous Cell Carcinoma
Takeda
P1/2
CCC
(48)
Showing 1051 to 1075 of 6,308 assets
Previous
Page 43 of 253
Next